These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9607818)

  • 1. Dynamin associates with Src-Homology Collagen (Shc) and becomes tyrosine phosphorylated in response to insulin.
    Baron V; Alengrin F; Van Obberghen E
    Endocrinology; 1998 Jun; 139(6):3034-7. PubMed ID: 9607818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional importance of amino-terminal domain of Shc for interaction with insulin and epidermal growth factor receptors in phosphorylation-independent manner.
    Sasaoka T; Ishihara H; Sawa T; Ishiki M; Morioka H; Imamura T; Usui I; Takata Y; Kobayashi M
    J Biol Chem; 1996 Aug; 271(33):20082-7. PubMed ID: 8702728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues.
    Thirone AC; Carvalho CR; Saad MJ
    Endocrinology; 1999 Jan; 140(1):55-62. PubMed ID: 9886807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the Src homology 2 (SH2) domain and C-terminus tyrosine phosphorylation sites of SH2-containing inositol phosphatase (SHIP) in the regulation of insulin-induced mitogenesis.
    Wada T; Sasaoka T; Ishiki M; Hori H; Haruta T; Ishihara H; Kobayashi M
    Endocrinology; 1999 Oct; 140(10):4585-94. PubMed ID: 10499514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A complex of GRB2-dynamin binds to tyrosine-phosphorylated insulin receptor substrate-1 after insulin treatment.
    Ando A; Yonezawa K; Gout I; Nakata T; Ueda H; Hara K; Kitamura Y; Noda Y; Takenawa T; Hirokawa N
    EMBO J; 1994 Jul; 13(13):3033-8. PubMed ID: 8039498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts.
    Takahashi Y; Tobe K; Kadowaki H; Katsumata D; Fukushima Y; Yazaki Y; Akanuma Y; Kadowaki T
    Endocrinology; 1997 Feb; 138(2):741-50. PubMed ID: 9003010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of Shc/Grb2- and Crk adaptor complexes containing tyrosine phosphorylated Cbl upon stimulation of the B-cell antigen receptor.
    Smit L; van der Horst G; Borst J
    Oncogene; 1996 Jul; 13(2):381-9. PubMed ID: 8710377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane localization of Src homology 2-containing inositol 5'-phosphatase 2 via Shc association is required for the negative regulation of insulin signaling in Rat1 fibroblasts overexpressing insulin receptors.
    Ishihara H; Sasaoka T; Ishiki M; Wada T; Hori H; Kagawa S; Kobayashi M
    Mol Endocrinol; 2002 Oct; 16(10):2371-81. PubMed ID: 12351701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional importance of Shc tyrosine 317 on insulin signaling in Rat1 fibroblasts expressing insulin receptors.
    Ishihara H; Sasaoka T; Ishiki M; Takata Y; Imamura T; Usui I; Langlois WJ; Sawa T; Kobayashi M
    J Biol Chem; 1997 Apr; 272(14):9581-6. PubMed ID: 9083103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shc is the predominant signaling molecule coupling insulin receptors to activation of guanine nucleotide releasing factor and p21ras-GTP formation.
    Sasaoka T; Draznin B; Leitner JW; Langlois WJ; Olefsky JM
    J Biol Chem; 1994 Apr; 269(14):10734-8. PubMed ID: 8144662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative involvement of Shc tyrosine 239/240 and tyrosine 317 on insulin induced mitogenic signaling in rat1 fibroblasts expressing insulin receptors.
    Ishihara H; Sasaoka T; Wada T; Ishiki M; Haruta T; Usui I; Iwata M; Takano A; Uno T; Ueno E; Kobayashi M
    Biochem Biophys Res Commun; 1998 Nov; 252(1):139-44. PubMed ID: 9813159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways.
    Sasaoka T; Ishiki M; Sawa T; Ishihara H; Takata Y; Imamura T; Usui I; Olefsky JM; Kobayashi M
    Endocrinology; 1996 Oct; 137(10):4427-34. PubMed ID: 8828504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin induces tyrosine phosphorylation of Shc and stimulates Shc/GRB2 association in insulin-sensitive tissues of the intact rat.
    Páez-Espinosa V; Carvalho CR; Alvarez-Rojas F; Janeri L; Velloso LA; Boschero AC; Saad MJ
    Endocrine; 1998 Apr; 8(2):193-200. PubMed ID: 9704577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins.
    Salcini AE; McGlade J; Pelicci G; Nicoletti I; Pawson T; Pelicci PG
    Oncogene; 1994 Oct; 9(10):2827-36. PubMed ID: 8084588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin and epidermal growth factor receptors regulate distinct pools of Grb2-SOS in the control of Ras activation.
    Waters SB; Chen D; Kao AW; Okada S; Holt KH; Pessin JE
    J Biol Chem; 1996 Jul; 271(30):18224-30. PubMed ID: 8663461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential modulation of the tyrosine phosphorylation state of the insulin receptor by IRS (insulin receptor subunit) proteins.
    Solow BT; Harada S; Goldstein BJ; Smith JA; White MF; Jarett L
    Mol Endocrinol; 1999 Oct; 13(10):1784-98. PubMed ID: 10517679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
    Liang L; Zhou T; Jiang J; Pierce JH; Gustafson TA; Frank SJ
    Endocrinology; 1999 May; 140(5):1972-83. PubMed ID: 10218944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
    Guvakova MA; Surmacz E
    Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
    Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
    Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shc and CEACAM1 interact to regulate the mitogenic action of insulin.
    Poy MN; Ruch RJ; Fernstrom MA; Okabayashi Y; Najjar SM
    J Biol Chem; 2002 Jan; 277(2):1076-84. PubMed ID: 11694516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.